Shareholder in Johnson & Johnson (NYSE: JNJ) plans $1.48M stock sale

Rhea-AI Filing Summary

A shareholder in Johnson & Johnson has filed a notice of proposed sale under Rule 144 for 6,226 shares of common stock. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $1,481,195.27.

The seller acquired these shares on 02/05/2026 by exercising a stock option that was originally granted on 02/12/2018, paying the exercise price in cash. The issuer reports 2,409,295,102 shares outstanding, providing context for the size of this planned sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6226	1481195.27	2409295102	02/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/05/2026	Option Granted - 02/12/2018	Issuer			6226	02/05/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for Johnson & Johnson (JNJ) disclose?

The Form 144 shows a Johnson & Johnson shareholder plans to sell 6,226 common shares under Rule 144. The proposed sale, via Fidelity Brokerage Services LLC on the NYSE, has an indicated aggregate market value of $1,481,195.27.

How many Johnson & Johnson (JNJ) shares are involved in this Rule 144 sale?

The notice covers a proposed sale of 6,226 Johnson & Johnson common shares. These shares were acquired on 02/05/2026 through the cash exercise of a stock option originally granted on 02/12/2018 by the issuer.

What is the market value of the Johnson & Johnson (JNJ) shares in this Form 144?

The filing reports an aggregate market value of $1,481,195.27 for the 6,226 Johnson & Johnson shares to be sold. This amount reflects the filer’s estimate for the planned Rule 144 transaction disclosed in the notice.

On which exchange and through which broker will the JNJ shares be sold?

The Form 144 indicates the 6,226 Johnson & Johnson common shares are planned to be sold on the NYSE through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island. This identifies both the trading venue and the executing broker.

When were the Johnson & Johnson (JNJ) shares acquired and how?

The shares covered by this Form 144 were acquired on 02/05/2026 via an option granted on 02/12/2018. The filing states the nature of payment as cash, indicating a standard cash exercise of the stock option to obtain 6,226 shares.

How large is this planned Johnson & Johnson (JNJ) sale relative to shares outstanding?

The notice lists 2,409,295,102 Johnson & Johnson shares outstanding. The proposed 6,226-share sale is small compared with this total, providing context for the transaction’s scale within the company’s overall common stock base.